Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cardiol Therapeutics Inc (CRDL.TO)

Cardiol Therapeutics Inc (CRDL.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 89,792
  • Shares Outstanding, K 61,925
  • Annual Sales, $ 79 K
  • Annual Income, $ -31,638 K
  • 60-Month Beta 0.72
  • Price/Sales 795.75
  • Price/Cash Flow N/A
  • Price/Book 1.18
Trade CRDL.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.61
  • Most Recent Earnings -0.14 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.31 +4.58%
on 05/12/22
2.20 -37.73%
on 04/25/22
-0.73 (-34.76%)
since 04/22/22
3-Month
1.31 +4.58%
on 05/12/22
2.60 -47.31%
on 04/14/22
-0.67 (-32.84%)
since 02/24/22
52-Week
1.31 +4.58%
on 05/12/22
6.19 -77.87%
on 09/27/21
-1.83 (-57.19%)
since 05/21/21

Most Recent Stories

More News
Why Orphan Drug Designation Offers Several Benefits

Palm Beach, FL – May 18, 2022 – FinancialNewsMedia.com News Commentary – The U.S. FDA prioritizes developing new treatments for rare diseases with the ability to grant Orphan Drug Designation. Here...

CRDL : 1.0750 (-5.70%)
CRDL.TO : 1.37 (-5.52%)
ABBV : 149.11 (+0.73%)
CRSP : 52.38 (-4.26%)
CYTK : 38.24 (-4.04%)
Heart Failure Treatment Offers Hope to Diabetics

Palm Beach, FL – May 11, 2022 – FinancialNewsMedia.com News Commentary – Diabetes and heart failure are closely linked. People with type 2 diabetes are two to four times more likely to develop heart...

CRDL : 1.0750 (-5.70%)
CRDL.TO : 1.37 (-5.52%)
LLY : 305.96 (+1.11%)
NVO : 107.98 (+0.13%)
SNY : 56.29 (+1.55%)
Stocks in play: Cardiol Therapeutics Inc.

Announced today that Cardiol's Chief Medical Officer, Dr. Andrew Hamer, will be participating in a panel ...

CRDL.TO : 1.37 (-5.52%)
Stocks in play: Cardiol Therapeutics Inc.

Has received approval from Health Canada to proceed with the Company's Phase II, multi-center, double-blind, ...

CRDL.TO : 1.37 (-5.52%)
Recent Surge for Intellectual Property & Patents in Psychedelic Therapies & Drug Development

Palm Beach, FL – June 15, 2021 – The modern psychedelic renaissance has empirically proven that psychedelic drugs are going to revolutionize mental health treatment. Before these incredibly promising...

OILFF : 0.0724 (-18.19%)
OILS.CN : 0.090 (-14.29%)
MNMD : 0.7764 (-1.83%)
LKYSF : 0.4800 (-3.63%)
NUMI.VN : 0.580 (+9.43%)
FTRPF : 5.7460 (-2.32%)
FTRP.CN : 5.550 (+1.46%)
CRTPF : 2.3000 (+5.50%)
CRDL.TO : 1.37 (-5.52%)
Cardiol Announces Upsize to Previously Announced Bought Deal Public Offering

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES NOR FOR DISSEMINATION IN THE UNITED STATES

CRDL.TO : 1.37 (-5.52%)
Cardiol Therapeutics Announces $15 Million Bought Deal Public Offering

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND  IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE  SERVICES NOR FOR DISSEMINATION IN THE UNITED STATES.

CRDL.TO : 1.37 (-5.52%)
Virtual Conference for Life Sciences Companies Broadcast Live September 17th, 2020

Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com

OTCM : 55.1001 (-0.18%)
SPHRY : 5.2950 (-3.02%)
SPL.AX : 0.755 (-3.82%)
VNRX : 2.31 (-4.15%)
KMPH : 4.52 (-3.62%)
ARHH : 7.6500 (-4.38%)
IOM.VN : 5.400 (-7.69%)
LIFE : 2.81 (-5.70%)
SWKH : 18.98 (-1.56%)
CRTPF : 2.3000 (+5.50%)
CRDL.TO : 1.37 (-5.52%)
XPHYF : 0.6259 (-2.96%)
Global Pandemic Creating Opportunities for Drug Companies to Earn Positive Market Attention

FN Media Group Presents Microsmallcap.com Market Commentary

GILD : 64.35 (+1.08%)
AZN : 66.65 (+0.36%)
PFE : 53.41 (+1.00%)
LLY : 305.96 (+1.11%)
CRDL.TO : 1.37 (-5.52%)
CRTPF : 2.3000 (+5.50%)
CannabisNewsBreaks – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) to Secure $11.25 Million in Bought Deal Public Offering

Cardiol Therapeutics (TSX: CRDL) (OTCQX: CRTPF), a leader in the production of pharmaceutical cannabidiol (“CBD”) and the development of innovative cannabidiol products for heart diseases, recently...

CRDL.TO : 1.37 (-5.52%)
CRTPF : 2.3000 (+5.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 1.67
2nd Resistance Point 1.61
1st Resistance Point 1.53
Last Price 1.37
1st Support Level 1.39
2nd Support Level 1.33
3rd Support Level 1.25

See More

52-Week High 6.19
Fibonacci 61.8% 4.33
Fibonacci 50% 3.75
Fibonacci 38.2% 3.17
Last Price 1.37
52-Week Low 1.31

See More

Business Summary

Cardiol Therapeutics Inc is a clinical-stage life sciences company developing therapies for cardiovascular disease (CVD). The lead product, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation being investigated in Phase II/III study in hospitalized patients testing positive for...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar